BioKDE: Biomedical Knowledge Discovery Engine
Sorted by:  
Results by Year
Article Type
Publication date


Custom range



  399,062 results (0.301 seconds)
Breast cancer.
Sibylle Loibl, Philip Poortmans, +2 authors, Giuseppe Curigliano.
Lancet. 2021 Apr 01; 397(10286):1750-1769. PMID: 33812473
Review.
The ubiquitin-proteasome system in breast cancer.
Dianwen Han,  Lijuan Wang,  Shan Jiang,  Qifeng Yang.
Trends Mol Med. 2023 Jun 14; 29(8):599-621. PMID: 37328395
Review.
Breast cancer.
Nadia Harbeck, Frédérique Penault-Llorca, +6 authors, Fatima Cardoso.
Nat Rev Dis Primers. 2019 Sep 23; 5(1):66. PMID: 31548545
Highly Cited. Review.
Therapeutic resistance to anti-oestrogen therapy in breast cancer.
Marie Will,  Jackson Liang,  Ciara Metcalfe,  Sarat Chandarlapaty.
Nat Rev Cancer. 2023 Jul 27; 23(10):673-685. PMID: 37500767     Free PMC article
Review.
Breast cancer.
Nadia Harbeck,  Michael Gnant.
Lancet. 2016 Nov 17; 389(10074):1134-1150. PMID: 27865536
Highly Cited. Review.
Clinical advances in PET-MRI for breast cancer.
Amy M Fowler,  Roberta M Strigel.
Lancet Oncol. 2022 Jan 02; 23(1):e32-e43. PMID: 34973230     Free PMC article
Review.
Targeting HER2-positive breast cancer: advances and future directions.
Sandra M Swain,  Mythili Shastry,  Erika Hamilton.
Nat Rev Drug Discov. 2022 Nov 07; 22(2):101-126. PMID: 36344672     Free PMC article
Review.
Deciphering breast cancer: from biology to the clinic.
Emma Nolan,  Geoffrey J Lindeman,  Jane E Visvader.
Cell. 2023 Mar 16; 186(8):1708-1728. PMID: 36931265
Review.
Impact of Nanomedicine in Women's Metastatic Breast Cancer.
Ali Akbar Ashkarran, Zijin Lin, +3 authors, Morteza Mahmoudi.
Small. 2023 Jun 03; :e2301385. PMID: 37269217
Review.
Adjuvant Chemotherapy in Older Women With Early Breast Cancer.
Dario Trapani.
J Clin Oncol. 2023 Jan 30; 41(9):1652-1658. PMID: 36716418
Review.
Breast Cancer in Men.
Sharon H Giordano.
N Engl J Med. 2018 Jun 14; 378(24):2311-2320. PMID: 29897847
Highly Cited. Review.
HER2-positive breast cancer.
Sibylle Loibl,  Luca Gianni.
Lancet. 2016 Dec 07; 389(10087):2415-2429. PMID: 27939064
Highly Cited. Review.
Key steps for effective breast cancer prevention.
Kara L Britt,  Jack Cuzick,  Kelly-Anne Phillips.
Nat Rev Cancer. 2020 Jun 11; 20(8):417-436. PMID: 32528185
Review.
Diabetes mellitus in breast cancer survivors: metabolic effects of endocrine therapy.
Nisha S Thomas,  Rebecca L Scalzo,  Elizabeth A Wellberg.
Nat Rev Endocrinol. 2023 Oct 02; :. PMID: 37783846
Review.
Systemic Therapy for Estrogen Receptor-Positive, HER2-Negative Breast Cancer.
Harold J Burstein.
N Engl J Med. 2020 Dec 29; 383(26):2557-2570. PMID: 33369357
Review.
HER2-targeted therapies - a role beyond breast cancer.
Do-Youn Oh,  Yung-Jue Bang.
Nat Rev Clin Oncol. 2019 Sep 23; 17(1):33-48. PMID: 31548601
Review.
Triple-negative breast cancer.
William D Foulkes,  Ian E Smith,  Jorge S Reis-Filho.
N Engl J Med. 2010 Nov 12; 363(20):1938-48. PMID: 21067385
Highly Cited. Review.
Epithelial-Mesenchymal Transition and Breast Cancer.
Yanyuan Wu,  Marianna Sarkissyan,  Jaydutt V Vadgama.
J Clin Med. 2016 Jan 26; 5(2):. PMID: 26821054     Free PMC article
Highly Cited. Review.
Late Recurrence Following Early Breast Cancer.
Alexandra Thomas,  Heather A Parsons,  Karen Lisa Smith.
J Clin Oncol. 2022 Mar 03; 40(13):1400-1406. PMID: 35239445     Free PMC article
Review.
Wnt signaling in triple-negative breast cancer.
Sö-G Pohl, N Brook, +3 authors, A Dharmarajan.
Oncogenesis. 2017 Apr 03; 6(4):e310. PMID: 28368389     Free PMC article
Highly Cited. Review.
1 2 3 4 5 6 7 8 9 10 Next